Capricor therapeutics, inc. (CAPR)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-2,084

-1,469

-1,606

-2,046

-2,519

-3,259

-4,136

-4,123

-3,671

12,305

-2,734

-3,472

-3,666

-4,518

-5,333

-4,688

-4,266

-3,346

-2,911

-3,123

-3,476

-1,928

-1,543

-1,533

-1,210

-4,304

-1,545

-1,624

-1,417

-380

-566

-352

-771

Adjustments to reconcile net loss to net cash used in operating activities:
Sub-award payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48

-

-

-

-

Accrued royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-22

9

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

80

107

105

105

102

98

76

65

61

61

61

61

60

60

54

25

24

23

6

3

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

0

0

-683

-683

-683

-683

-911

-911

-911

-911

-911

-1,041

-1,041

-1,041

-1,041

11,458

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Note discount arising from beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss on disposal of fixed asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gain on sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Depreciation and amortization

32

42

42

43

43

43

41

38

34

34

33

37

38

33

26

33

31

31

28

26

24

13

12

9

6

6

6

7

6

15

1

1

1

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

421

0

Write-off of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Common stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Stock-based compensation

287

128

225

124

223

390

430

446

457

413

427

398

471

463

554

654

290

391

266

342

572

149

155

107

84

85

71

64

41

27

51

82

171

Change in assets - (increase) decrease:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-599

-1,448

-929

-722

-678

3,823

-846

-1,665

3,067

-515

515

-

-

-

-

Receivables

30

-13

-42

21

-82

32

-114

-19

-37

83

-52

115

-26

160

-155

-85

91

-191

23

-366

386

99

260

0

0

-123

-234

-79

-329

-

-

-

-

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

-2

-8

-

-

-

-

Prepaid expenses and other current assets

-137

442

-246

-50

-298

297

38

-134

21

310

-49

-158

55

224

-121

-82

110

118

-38

-72

-32

130

-18

-47

-52

153

-7

-2

-7

-

-

-

-

Other assets

-12

-5

-4

-4

-18

-5

-49

49

61

34

0

-0

0

0

-0

-9

1

-63

63

0

14

0

0

29

0

-2

7

0

0

-

-

-

-

Change in liabilities - increase (decrease):
Accounts payable and accrued expenses

420

-71

-572

57

314

-594

537

-202

-87

231

-912

-328

-532

-881

996

-300

693

221

-370

-67

1,046

-25

-100

174

22

618

-185

474

165

-

-

-

-

Accounts payable and accrued expenses, related party

6

9

-33

8

-68

-25

18

44

-104

74

-211

201

-379

-209

152

75

118

-227

40

-93

198

132

-199

18

57

147

-19

-76

133

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-55

-50

Other non-current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

88

-205

-110

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-39

48

-4

Due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-28

-61

59

NET CASH USED IN OPERATING ACTIVITIES

-1,218

-1,785

-1,651

-1,777

-1,607

-3,771

-2,982

-3,691

-3,417

-2,667

-3,189

-3,698

-4,675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-494

-852

-603

CASH FLOWS FROM INVESTING ACTIVITIES:
Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-3

3

-

-

-

-

NET CASH USED IN OPERATING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,883

-4,181

-3,642

-3,244

-1,878

-2,052

-2,146

-2,221

-6,016

11,342

179

-4,511

-635

-1,176

-

-

-

-

Purchase of marketable securities

6,130

5,986

0

0

15

3,010

5,997

6,001

3,001

7,983

4,998

2,007

3,996

12,987

2,503

0

2,505

2

2,499

0

15,487

0

0

-226

226

0

0

184

42

-

-

-

-

Proceeds from sales and maturities of marketable securities

12,117

0

0

0

3,000

6,000

6,000

6,000

5,000

5,000

4,000

7,000

8,000

2,500

2,500

0

8,000

5,000

5,000

0

0

326

-0

-227

227

1,295

1,131

1,199

488

-

-

-

-

Purchases of property and equipment

-

-

-

-

-

-15

145

0

186

0

16

12

3

105

10

29

45

5

73

23

27

16

30

23

92

3

15

34

3

13

0

0

0

Payments for leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

12

0

9

0

0

23

0

-

-

-

-

-

-

-

-

Other investing activities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40

21

2

-

-

-

-

-

-

-

-

Proceeds from sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Payments for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET CASH PROVIDED BY INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-31

5,448

4,992

2,414

-23

-15,524

375

-71

-68

-94

-

-

-

-

-

-

-

-

Proceeds from reverse merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Payments for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-

-

-

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

431

-

-

-

-

NET CASH PROVIDED BY INVESTING ACTIVITIES

5,986

-5,986

0

0

2,984

3,004

-142

-1

1,811

-2,983

-1,014

4,979

4,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Repayment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net proceeds from sale of common stock

4,460

4,610

2,587

543

1,433

512

1,053

2,775

2,373

2,769

4,621

3,681

0

0

9,935

0

3,929

0

0

0

16,446

0

0

0

0

-

-

-

-

-

0

0

0

Proceeds from exercise of pre-funded common stock warrants and warrants

89

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from loan payable

-

-

-

-

-

-

-

-

-

250

0

250

0

0

1,750

2,000

1,000

0

0

0

0

-

-

-

-

0

3,067

0

857

-

-

-

-

Proceeds from stock options

-

-

-

-

-

0

0

0

139

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock awards, warrants, and options

-

-

-

-

-

-

-

-

-

-

-

-

-

0

12

0

0

0

10

0

34

0

2

1

0

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Costs related to the issuance of preferred stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

857

-

-

-

-

Proceeds from sale of common stock in private placement, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,194

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

4,549

4,610

2,587

545

1,433

512

1,053

2,775

2,512

3,026

4,621

3,931

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,194

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

4,930

0

10

0

16,481

0

516

4,688

0

-

-

-

-

-

-

-

-

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

9,318

-3,161

936

-1,231

2,810

-254

-2,071

-917

906

-2,625

417

5,213

-675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,198

1,349

-819

-1,900

-1,095

-1,770

-1,776

-1,396

11,249

1,453

-342

335

112

-623

-494

341

-603

SUPPLEMENTAL DISCLOSURES:
Interest paid in cash

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

2

0

0

0

0

0

0

0

0

0

0

0

0

0

Income taxes paid in cash

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Warrants issued in satisfaction of accrued liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Warrants issued to placement agent and investors in connection with private placements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Warrants issued to investors in connection with registered direct offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

611

0

Conversion of notes payable and interest to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Common shares of SMI issued in reverse merger transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0